share_log

Exagen Analyst Ratings

Benzinga Analyst Ratings ·  Nov 17, 2022 20:06
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/17/2022 105.88% BTIG $10 → $7 Maintains Buy
11/15/2022 105.88% Canaccord Genuity $8 → $7 Maintains Buy
05/13/2022 400% Keybanc $20 → $17 Maintains Overweight
03/25/2022 488.24% Keybanc $30 → $20 Maintains Overweight
11/11/2021 782.35% Keybanc $33 → $30 Maintains Overweight
04/15/2021 635.29% Canaccord Genuity → $25 Initiates Coverage On → Buy
03/02/2021 870.59% Keybanc $32 → $33 Maintains Overweight
11/10/2020 841.18% Keybanc → $32 Initiates Coverage On → Overweight
10/08/2020 429.41% BTIG → $18 Initiates Coverage On → Buy
06/02/2020 488.24% Cantor Fitzgerald $19 → $20 Assumes → Overweight
11/13/2019 635.29% Cantor Fitzgerald $18 → $25 Maintains Overweight
10/14/2019 429.41% Cantor Fitzgerald → $18 Initiates Coverage On → Overweight
10/14/2019 400% Cowen & Co. → $17 Initiates Coverage On → Outperform
10/14/2019 William Blair Initiates Coverage On → Outperform

What is the target price for Exagen (XGN)?

The latest price target for Exagen (NASDAQ: XGN) was reported by BTIG on November 17, 2022. The analyst firm set a price target for $7.00 expecting XGN to rise to within 12 months (a possible 105.88% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Exagen (XGN)?

The latest analyst rating for Exagen (NASDAQ: XGN) was provided by BTIG, and Exagen maintained their buy rating.

When is the next analyst rating going to be posted or updated for Exagen (XGN)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exagen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exagen was filed on November 17, 2022 so you should expect the next rating to be made available sometime around November 17, 2023.

Is the Analyst Rating Exagen (XGN) correct?

While ratings are subjective and will change, the latest Exagen (XGN) rating was a maintained with a price target of $10.00 to $7.00. The current price Exagen (XGN) is trading at is $3.40, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment